BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Skofler C, Kleinegger F, Krassnig S, Birkl-Toeglhofer AM, Singer G, Till H, Benesch M, Cencic R, Porco JA Jr, Pelletier J, Castellani C, Raicht A, Izycka-Swieszewska E, Czapiewski P, Haybaeck J. Eukaryotic Translation Initiation Factor 4AI: A Potential Novel Target in Neuroblastoma. Cells 2021;10:301. [PMID: 33540613 DOI: 10.3390/cells10020301] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Fu L, Wang Z, Jiang F, Wei G, Sun L, Guo C, Wu J, Zhu J, Granito A. High Expression of EIF4G2 Mediated by the TUG1/Hsa-miR-26a-5p Axis Is Associated with Poor Prognosis and Immune Infiltration of Gastric Cancer. Journal of Oncology 2022;2022:1-25. [DOI: 10.1155/2022/9342283] [Reference Citation Analysis]
2 Shichino Y, Iwasaki S. Compounds for selective translational inhibition. Current Opinion in Chemical Biology 2022;69:102158. [DOI: 10.1016/j.cbpa.2022.102158] [Reference Citation Analysis]
3 Chen M, Kumakura N, Muller R, Shichino Y, Nishimoto M, Mito M, Gan P, Ingolia NT, Shirasu K, Ito T, Iwasaki S. A parasitic fungus employs mutated eIF4A to survive on rocaglate-synthesizing Aglaia plants.. [DOI: 10.1101/2022.07.04.498659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Shimada H, Ikegaki N. Genetic and Histopathological Heterogeneity of Neuroblastoma and Precision Therapeutic Approaches for Extremely Unfavorable Histology Subgroups. Biomolecules 2022;12:79. [DOI: 10.3390/biom12010079] [Reference Citation Analysis]